Clinical trial
Risedronate for the Treatment of Osteoporosis for People With Spinal Cord Injury
NCT00138866 · Toronto Rehabilitation Institute, Other · Completed
Key facts
| NCT number | NCT00138866 |
|---|---|
| Title | Risedronate for the Treatment of Osteoporosis for People With Spinal Cord Injury |
| Official title | Risedronate for Treatment of Sublesional Osteoporosis After Spinal Cord Injury |
| Lead sponsor | Toronto Rehabilitation Institute, Other |
| Collaborators | The Physicians' Services Incorporated Foundation St. Joseph's Health Care London |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | Risedronate |
| Enrollment | 46 |
| Start date | Nov 1, 2004 |
| Primary completion | Jan 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Aug 30, 2005 |
| Last update posted | Oct 13, 2010 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: